Asiatic Laboratories Limited (DSE: ASIATICLAB)
Health Care · Pharmaceuticals · BD
Tk117.20
+2.00% today · +124.5% 1Y
Asiatic Laboratories Limited (DSE: ASIATICLAB) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $116.44M.
Over the last twelve months the share price has gained 124.5%, trading between 44.20 and 146.90.
Tweenvest scores Asiatic Laboratories Limited across four factors: value 37/100, growth 0/100, dividend 39/100. Its strongest factor is dividend.
ASIATICLAB price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $116.44M
- Revenue (TTM)
- $23.69M
- P/E
- 27.00
- EPS
- 4.34
- Dividend yield
- 0.85%
- Beta (5Y)
- 0.59
- 52-week high
- Tk146.90
- 52-week low
- Tk44.20
- Avg volume (3M)
- —
- Shares outstanding
- 122.39M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,247.58 | +0.05% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $271.39 | -0.60% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $151.23 | +0.38% |
| Roche Holding AGSWX: ROP | $368.80B | CHF371.10 | +0.19% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £121.32 | +0.18% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $28.02 | +0.18% |
Figures last refreshed Aug 18, 2026.